Updates are available Correction dated 2018-05-17
Click to view Correction: https://doi.org/10.1038/s41541-018-0054-8
-
Authors
Ma, Jingjiao
Lee, Jinhwa
Liu, Haixia
Mena, Ignacio
Davis, A. Sally
Sunwoo, Sun Young
Lang, Yuekun
Duff, Michael
Morozov, Igor
Li, Yuhao
Yang, Jianmei
García-Sastre, Adolfo
Richt, Juergen A.
Ma, Wenjun
- License Information
-
More Information
Article History
Received: 5 June 2017
Revised: 25 September 2017
Accepted: 3 October 2017
First Online: 4 December 2017
Change Date: 17 May 2018
Change Type: Correction
Change Details: The wrong contract number was quoted in the Acknowledgments section of this Article. This work was supported by NIAID funded Centers of Excellence for Influenza Research and Surveillance under contract number HHSN272201400006C, not HHSN266200700006C as indicated in the original paper.
Competing interests
: A.G-S is an inventor of patents encompassing NDV-vectored vaccines owned by the Icahn School of Medicine at Mount Sinai. The remaining authors declare that they have no Competing financial interests.
